Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 2:18 AM
Ignite Modification Date:
2025-12-26 @ 12:48 AM
NCT ID:
NCT01454934
Group ID:
EG001
Title:
Arm B: Vinorelbine, Gemcitabine, Docetaxel, or Pemetrexed
Description:
TPC: Vinorelbine (30 mg/m\^2) was administered IV on Day 1 every 7 days, Gemcitabine (1250 mg/m\^2) was administered IV on Days 1 and 8 every 21 days (or 1000 mg/m\^2 IV on Days 1, 8, and 15 every 28 days), Docetaxel (75 mg/m\^2) was administered IV on Day 1 every 21 days, or Pemetrexed (500 mg/m\^2) was administered IV on Day 1 every 21 days (nonsquamous histology only).
Deaths Number Affected:
21
Deaths Number At Risk:
None
Serious Number Affected:
86
Serious Number At Risk:
268
Other Number Affected:
261
Other Number At Risk:
268
Study:
NCT01454934
Results Section:
NCT01454934
Adverse Events Module:
NCT01454934